dr. richards on using parp inhibitors in mutated metastatic pancreatic cancer
Published 4 years ago • 84 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
0:47
dr. richards on parp inhibition in pancreatic cancer
-
1:58
dr. richards on the phase iii polo trial in brca-mutated pancreatic cancer
-
0:53
dr. richards on genetic testing in metastatic pancreatic cancer
-
1:19
dr. richards on secondary endpoints of the polo trial in pancreatic cancer
-
3:45
parp inhibitors gbrca1/2-mutated pancreatic cancer
-
0:59
dr. simeone on impact of parp inhibitors on pancreatic cancer
-
5:02
parp inhibitors in pancreatic cancer
-
1:25
dr. mizrahi on addition of parp inhibitors to chemotherapy in mutated pancreatic cancer
-
1:59
dr. o’reilly on the utility of parp inhibitors in pancreatic cancer
-
2:59
parp inhibitor olaparib as treatment for pancreatic cancer patients with brca gene mutations
-
1:18
dr. o’reilly on ongoing trials with parp inhibitors in pancreatic cancer
-
1:48
dr. chung on sequencing chemotherapy regimens in metastatic pancreatic cancer
-
1:07
quality of life data for parp inhibitor shows promise for pancreatic cancer treatment
-
0:52
dr. cohn on frontline therapies in metastatic pancreatic cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
2:08
dr. lorusso on parp inhibitors in triple-negative breast cancer
-
10:42
brca pancreatic cancer maintenance debate: parp inhibitor or continued chemo? - parp inhibitor
-
2:30
dr. matulonis on toxicities with parp inhibitors in ovarian cancer
-
0:45
dr. coffman on safety concerns with parp inhibitors in ovarian cancer